letrozole / Generic mfg. 
Welcome,         Profile    Billing    Logout  
 114 Diseases   361 Trials   361 Trials   7200 News 


«12...5859606162636465666768...100101»
  • ||||||||||  letrozole / Generic mfg.
    Journal:  Evidence-based treatments for couples with unexplained infertility: a guideline. (Pubmed Central) -  Jul 24, 2020   
    The treatment of unexplained infertility is by necessity empiric. For most couples, the best initial therapy is a course (typically 3 or 4 cycles) of ovarian stimulation with oral medications and intrauterine insemination (OS-IUI) followed by in vitro fertilization for those unsuccessful with OS-IUI treatments.
  • ||||||||||  Prolia (denosumab) / Amgen, Daiichi Sankyo, GSK, letrozole / Generic mfg., Faslodex (fulvestrant) / AstraZeneca
    Clinical, Journal:  Two Cases of Stage Ⅳ Occult Breast Cancer (Pubmed Central) -  Jul 24, 2020   
    However, after 6 months, she discontinued the treatment. Our results suggested that effective control could be achieved through systemic therapy and local therapy was not necessary for Stage Ⅳ occult breast cancer.
  • ||||||||||  letrozole / Generic mfg., Arimidex (anastrozole) / AstraZeneca, Remedica, tamoxifen / Generic mfg.
    [VIRTUAL] Lipid changes during endocrine therapy in breast cancer patients: The results of a 5-year real-world retrospective analysis (On-Demand) -  Jul 21, 2020 - Abstract #ESMO2020ESMO_527;    
    Results For premenopausal BC patients, LDL levels rapidly decreased at 1 year in the tamoxifene (TAM) group compared with baseline (p<0.05), and the decline remained for the following 4 years...For postmenopausal BC patients, there was no statistical difference in the lipid profiles (TG, TC, LDL and HDL) in letrozole (LET), anastrozole (ANA) and exemestane (EXE) group compared with the control group, respectively...Legal entity responsible for the study: West China School of Medicine/West China Hospital, Sichuan University. Funding: Has not received any funding.
  • ||||||||||  Phase classification, Enrollment change, Trial completion date, Trial primary completion date:  EUROPA: ExclUsive endocRine Therapy Or Radiation theraPy for Women Aged ?70 Years Early Stage Breast Cancer (clinicaltrials.gov) -  Jul 14, 2020   
    P3,  N=926, Not yet recruiting, 
    Communicated by Ramaswamy H. Sarma. Phase classification: P2/3 --> P3 | N=600 --> 926 | Trial completion date: Mar 2026 --> Dec 2025 | Trial primary completion date: Mar 2023 --> Dec 2025
  • ||||||||||  NN1213 / Novo Nordisk
    Trial completion date, Trial primary completion date:  Impact of Omega 3 Fatty Acid Supplementation on Aromatase in Obese Subjects (clinicaltrials.gov) -  Jul 14, 2020   
    P1,  N=60, Recruiting, 
    Phase classification: P2/3 --> P3 | N=600 --> 926 | Trial completion date: Mar 2026 --> Dec 2025 | Trial primary completion date: Mar 2023 --> Dec 2025 Trial completion date: Jun 2021 --> Jun 2022 | Trial primary completion date: Jun 2020 --> Jun 2021
  • ||||||||||  letrozole / Generic mfg.
    Enrollment open:  Novel Therapy for Poor Responders Management (clinicaltrials.gov) -  Jul 7, 2020   
    P=N/A,  N=100, Recruiting, 
    Trial completion date: May 2023 --> Jan 2023 | Trial primary completion date: May 2023 --> Jan 2023 Not yet recruiting --> Recruiting
  • ||||||||||  letrozole / Generic mfg.
    Phase classification, Trial completion date:  RCT of Fixed vs Titrated Letrozole in Breast Cancer Patient Undergoing IVF (clinicaltrials.gov) -  Jul 7, 2020   
    P4,  N=41, Active, not recruiting, 
    Trial registration NCT01740427; Funding: Pfizer. Phase classification: P=N/A --> P4 | Trial completion date: Dec 2019 --> May 2021
  • ||||||||||  Ibrance (palbociclib) / Pfizer
    [VIRTUAL] A Tale of Unexplained Pneumotoxicity: The Dangers of Palbociclib (ATS 2020 Virtual) -  Jul 6, 2020 - Abstract #ATSI2020ATS-I_3978;    
    An exhaustive laboratory workup was done in order to exclude other causes that may result in diffuse lung injury, including infection, environmental exposure, and malignancy. This should not deter physicians from using palbociclib as a chemotherapeutic agent in patient with advanced stage breast cancer, as the PALOMA-2 trial has shown that combining palbociclib with letrozole can lead to a median progression free survival of thirteen months in patients who are ER-positive and HER2-negative.
  • ||||||||||  letrozole / Generic mfg., methotrexate / Generic mfg.
    Journal:  Aromatase inhibitor letrozole: a novel treatment for ectopic pregnancy. (Pubmed Central) -  Jul 6, 2020   
    To our knowledge, this is the first report in the literature on the success of letrozole for the medical treatment of ectopic pregnancy. The promisingly high resolution rate and better safety profile that letrozole has compared with a chemotherapeutic agent such as methotrexate should encourage further studies.
  • ||||||||||  letrozole / Generic mfg., Arimidex (anastrozole) / AstraZeneca, Remedica, exemestane / Generic mfg.
    Review, Journal:  Polyphenolic natural products and natural product-inspired steroidal mimics as aromatase inhibitors. (Pubmed Central) -  Jun 29, 2020   
    Pursuit of this strategy over the last few decades has been largely successful although complications and challenges remain. This review highlights the aromatase activity of natural stilbenes, chalcones, and flavanones and synthetically inspired versions thereof and draws attention to new and under-investigated areas within each class worthy of pursuit.